Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors. 2002

A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
Discovery Research Laboratory, Tanabe Seiyaku Co. Ltd, Saitama, Japan. a-nakata@tanabe.co.jp

Even though the existence of phosphodiesterase (PDE) 7 in T cells has been proved, the lack of a selective PDE7 inhibitor has confounded an accurate assessment of PDE7 function in such cells. In order to elucidate the role of PDE7 in human T cell function, the effects of two PDE inhibitors on PDE7A activity, cytokine synthesis, proliferation and CD25 expression of human peripheral blood mononuclear cells (PBMC) were determined. Recombinant human PDE7A was obtained and subjected to cyclic AMP-hydrolysis assay. PBMC of Dermatophagoides farinae mite extract (Df)-sensitive donors were stimulated with the relevant antigen or an anti-CD3 monoclonal antibody (MoAb). PBMC produced IL-5 and proliferated in response to stimulation with Df, while stimulation with anti-CD3 MoAb induced CD25 expression and messenger RNA (mRNA) synthesis of IL-2, IL-4 and IL-5 in peripheral T cells. A PDE inhibitor, T-2585, which suppressed PDE4 isoenzyme with high potency (IC50 = 0.00013 microM) and PDE7A with low potency (IC50 = 1.7 microM) inhibited cytokine synthesis, proliferation and CD25 expression in the dose range at which the drug suppressed PDE7A activity. A potent selective inhibitor of PDE4 (IC50 = 0.00031 microM), RP 73401, which did not effectively suppress PDE7A (IC50 > 10 microM), inhibited the Df- and anti-CD3 MoAb-stimulated responses only weakly, even at 10 microM. PDE7 may play a critical role in the regulation of human T cell function, and thereby selective PDE7 inhibitors have the potential to be used to treat immunological and inflammatory disorders.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.

Related Publications

A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
August 2020, International journal of molecular sciences,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
May 1997, British journal of pharmacology,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
January 2006, Critical reviews in immunology,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
November 1984, Endocrinology,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
September 2015, International immunopharmacology,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
January 1997, International journal of clinical & laboratory research,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
February 1993, Archives des maladies du coeur et des vaisseaux,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
May 2001, Blood,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
September 2018, Pediatric pulmonology,
A Nakata, and K Ogawa, and T Sasaki, and N Koyama, and K Wada, and J Kotera, and H Kikkawa, and K Omori, and O Kaminuma
April 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!